{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:59:47Z","timestamp":1774123187698,"version":"3.50.1"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T00:00:00Z","timestamp":1292803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014307","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T22:09:15Z","timestamp":1292882955000},"page":"e14307","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Influenza Pandemic Waves under Various Mitigation Strategies with 2009 H1N1 as a Case Study"],"prefix":"10.1371","volume":"5","author":[{"given":"Suma","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2010,12,20]]},"reference":[{"issue":"25","key":"ref1","first-page":"2595","article-title":"The signature features of influenza pandemics - implications for policy.","volume":"360","author":"MA Miller","year":"2009"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1086\/524065","article-title":"Epidemiologic characterization of the 1918 influenza pandemic summer wave in copenhagen: implications for pandemic control strategies.","volume":"197","author":"V Andreasen","year":"2008","journal-title":"J Infect Dis"},{"key":"ref3","first-page":"89","article-title":"Pandemic influenza and mortality: past evidence and projections for the future.","author":"L Simonsen","year":"2005"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1086\/589716","article-title":"Prioritization of influenza pandemic vaccination to minimize years of life lost.","volume":"198","author":"MA Miller","year":"2008","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/jac\/dkl376","article-title":"Use of neuraminidase inhibitors to combat pandemic influenza.","volume":"58","author":"J Democratis","year":"2006","journal-title":"J Antimicrobl Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. us oral neuraminidase study group.","volume":"283","author":"JJ Treanor","year":"2000","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki018","article-title":"Oseltamivir (tamiflu(r)) and its potential for use in the event of an influenza pandemic.","volume":"55","author":"P Ward","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.","volume":"285","author":"R Welliver","year":"2001","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.vaccine.2010.01.002","article-title":"Vaccination against pandemic influenza a\/h1n1v in england: A real-time economic evaluation.","volume":"28","author":"M Baguelin","year":"2010","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-9-187","article-title":"Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight european countries.","volume":"9","author":"N Hens","year":"2009","journal-title":"BMC Infectious Diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature04017","article-title":"Strategies for containing an emerging influenza pandemic in southeast asia.","volume":"437","author":"NM Ferguson","year":"2005","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic.","volume":"442","author":"NM Ferguson","year":"2006","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid1209.041344","article-title":"Potential impact of antiviral drug use during influenza pandemic.","volume":"9","author":"R Gani","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1073\/pnas.0601266103","article-title":"Mitigation strategies for pandemic influenza in the united states.","volume":"103","author":"TC Germann","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/aje\/kwh092","article-title":"Containing pandemic influenza with antiviral agents.","volume":"159","author":"IMJ Longini","year":"2004","journal-title":"Am J Epidemiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source.","volume":"309","author":"IMJ Longini","year":"2005","journal-title":"Science"},{"issue":"19","key":"ref17","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1176062","article-title":"Who rapid pandemic assessment collaboration: Pandemic potential of a strain of influenza a (h1n1): early findings.","volume":"324","author":"C Fraser","year":"2009","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1750-2659.2009.00100.x","article-title":"Initial human transmission dynamics of the pandemic (h1n1) 2009 virus in north america.","volume":"3","author":"B Pourbohloul","year":"2009","journal-title":"Influenza Other Respiratory Viruses"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"pii:19205","DOI":"10.2807\/ese.14.19.19205-en","article-title":"A preliminary estimation of the reproduction ratio for new influenza a (h1n1) from the outbreak in mexico: March-april 2009.","volume":"14","author":"PY Bo\u00eblle","year":"2009","journal-title":"Euro Surveill"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1750-2659.2009.00106.x","article-title":"Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza a\/h1n1 pandemic in the usa.","volume":"3","author":"LF White","year":"2009","journal-title":"Influenza Other Respi Viruses"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1503\/cmaj.091807","article-title":"Estimated epidemiologic parameters and morbidity associated with pandemic h1n1 influenza.","volume":"182","author":"AR Tuite","year":"2010","journal-title":"CMAJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1503\/cmaj.091641","article-title":"Modelling mitigation strategies for pandemic (h1n1).","volume":"181","author":"MZ Gojovic","year":"2009","journal-title":"CMAJ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1175570","article-title":"Optimizing influenza vaccine distribution.","volume":"325","author":"J Medlock","year":"2009","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-7-73","article-title":"Post-exposure prophylaxis during pandemic outbreaks.","volume":"7","author":"SM Moghadas","year":"2009","journal-title":"BMC Medicine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tpb.2007.10.003","article-title":"An in-host model of acute infection: Measles as a case study.","volume":"73","author":"JM Heffernan","year":"2008","journal-title":"Theor Popul Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1750-2659.2010.00161.x","article-title":"Highly conserved cross-reactive cd4+ t-cell ha-epitopes of seasonal and the 2009 pandemic influenza viruses.","volume":"4","author":"VRSK Duvvuri","year":"2010","journal-title":"Influenza and Other Respiratory Viruses"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1016\/S0166-3542(01)00129-2","article-title":"The importance of specific virus diagnosis and monitoring for antiviral treatment.","volume":"51","author":"A Linde","year":"2001","journal-title":"Antiviral Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11538-007-9257-2","article-title":"A delay differential model for pandemic influenza with antiviral treatment.","volume":"70","author":"ME Alexander","year":"2008","journal-title":"Bull Math Biol"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza.","volume":"353","author":"A Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"ref30","article-title":"Mathematical Epidemiology of Infectious Diseases.","author":"O Diekmann","year":"2000"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0000605-200912150-00157","article-title":"Effectiveness and cost-effectiveness of vaccination against pandemic influenza (h1n1) 2009.","volume":"151","author":"N Khazeni","year":"2009","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.1122947","article-title":"Emergence of drug-resistant influenza virus: population dynamical considerations.","volume":"312","author":"RR Regoes","year":"2006","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s00285-002-0186-2","article-title":"Dynamics of annual influenza a epidemics with immuno-selection.","volume":"46","author":"V Andreasen","year":"2003","journal-title":"J Math Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"825842","DOI":"10.1007\/s002850050079","article-title":"The dynamics of cocirculatinginfluenza strains conferring partial cross-immunity.","volume":"35","author":"V Andreasen","year":"1997","journal-title":"J Math Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tpb.2003.10.002","article-title":"Influenza drift and epidemic size: the race between generating and escaping immunity.","volume":"65","author":"MF Boni","year":"2004","journal-title":"Theor Popul Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1073\/pnas.252512799","article-title":"Dynamics andselection of many-strain pathogens.","volume":"99","author":"JR Gog","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref37","first-page":"169184","article-title":"A status-based approach to multiple strain dynamics.","volume":"44","author":"JR Gog","year":"2002","journal-title":"J Math Biol"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","article-title":"Infectious Diseases of Humans.","author":"RM Anderson","year":"1991"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1524-4733.2008.00437.x","article-title":"Economic evaluation of influenza pandemic mitigation strategies in the united states using a stochastic microsimulation transmission model.","volume":"12","author":"B Sander","year":"2009","journal-title":"Value Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1098\/rspb.2009.0057","article-title":"Implications of vaccination and waning immunity.","volume":"276","author":"JM Heffernan","year":"2009","journal-title":"Proc R Soc B"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","article-title":"Antiviral resistance and the control of pandemic influenza.","volume":"4","author":"M Lipsitch","year":"2007","journal-title":"PLoS Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance - disabling our influenza defenses.","volume":"353","author":"A Moscona","year":"2005","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza.","volume":"360","author":"A Moscona","year":"2009","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T05:20:42Z","timestamp":1712035242000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014307"}},"subtitle":[],"editor":[{"given":"Alison P.","family":"Galvani","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,20]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014307","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,20]]}}}